个人简介
Matteo Rocco Pastore医生在IRCCS圣拉斐尔科学研究医院糖尿病和内分泌代谢综合科室负责管理糖尿病、内分泌代谢疾病的全科医学科，在Emanuele Bosi教授的指导下开展工作。
1986年，Pastore医生毕业于米兰大学医学院，1989年和2004年分别在米兰大学和圣拉斐尔生命健康大学获得糖尿病学和内分泌学专业学位。
在临床工作方面，Pastore医生在全科医学科担任治疗医师，负责糖尿病和内分泌代谢疾病方向，并参加医院的多学科会诊。Pastore医生还会进行糖尿病的门诊临床活动，尤其关注1型糖尿病的治疗。
他作为国际研究方案TrialNet的共同带头人，在1型糖尿病及其并发症的预测和预防领域开展研究活动。
他以作者或共同作者的身份在行业学术期刊上发表了多篇论文，也参与了部分书籍章节的编写，共计50余篇文章，H指数为11（WoS）。多次参加意大利国内外的行业会议。
教育背景
米兰大学
1986年，医学博士学位
米兰大学
1989年，糖尿病专业学位
圣拉斐尔生命健康大学
2004年，内分泌学专业学位
出版物
最新出版物
Endothelial progenitor cells carrying monocyte markers are selectively abnormal in type 1 diabetic patients with early retinopathy
https://www.ncbi.nlm.nih.gov/pubmed/22338095
Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk
Diabetologia. May; 49(5):881-90, 2006
扩展阅读
Increased clonogenic potential of circulating endothelial progenitor cells in patients with type 1 diabetes and proliferative retinopathy
Diabetologia. May;49(5):1109-11, 2006.
扩展阅读
Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk
Diabetologia, May;49(5):881-90, 2006.
扩展阅读
Lactulose and mannitol intestinal permeability detected by capillary electrophoresis
J Chromatogr B Analyt Technol Biomed Life Sci. Apr 13;834(1-2):183-7, 2006
扩展阅读
European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes
Lancet 363(9413):925-34, 2004
扩展阅读
Six months of gluten-free diet do not change islet autoantibodies, but improve insulin secretion in subjects at high risk for type 1 diabetes
J Clin Endocrinol Metab 88: 162-165, 2003.
扩展阅读
Update on Worldwide Efforts to Prevent Type 1 Diabetes
Ann N Y Acad Sci 2008;1150:190-196. PMID 19120293, NIHMS225042
扩展阅读
Mixed-Meal Tolerance Test Versus Glucagon Stimulation Test for the Assessment of β-Cell Function in Therapeutic Trials in Type 1 Diabetes
Diabetes Care 2008;31:1966-1971. PMID 18628574, PMC2251636
扩展阅读
The TrialNet Natural History Study of the Development of Type 1 Diabetes: objectives, design, and initial results.
Pediatric Diabetes 2009;10:97-104. PMID 18823409
扩展阅读
The Validation of the Diabetes Prevention Trial-Type 1 Risk Score and the detection of Pre-Diabetes in the TrialNet Natural History Study
Diabetes Care 2011;34:1785-1787. PMID: 21680724,PMC3142063.
扩展阅读
Zinc transporter-8 autoantibodies improve prediction of type 1 diabetes in relatives positive for the standard biochemical autoantibodies
Diabetes Care. 2012 Jun;35(6):1213-8. doi: 10.2337/dc11- 2081. Epub 2012 Mar 23
扩展阅读
The application of the diabetes prevention trial-type 1 risk score for identifying a preclinical state of type 1 diabetes
Diabetes Care. 2012 Jul;35(7):1552-5. doi: 10.2337/dc12-0011. Epub 2012 Apr 30
扩展阅读
Performance of HbA1c as an early diagnostic indicator of type 1 diabetes in children and youth
Diabetes Care. 2012 Sep;35(9):1821-5. Epub 2012 Jun 14
扩展阅读
The prediction of type 1 diabetes by multiple autoantibody levels and their incorporation into an autoantibody risk score in relatives of type 1 diabetic patients
Diabetes Care. 2013 Sep;36(9):2615-20. doi: 10.2337/dc13-0425. Epub 2013 Jul 1
扩展阅读
Use of Dried Capillary Blood Sampling for Islet Autoantibody Screening in Relatives: A Feasibility Study.
Diabetes Technol Ther. 2015 Dec;17(12):867-71. doi: 10.1089/dia.2015.0133. Epub 2015 Sep 16
扩展阅读
The relationship between BMI and insulin resistance and progression from single to multiple autoantibody positivity and type 1 diabetes among TrialNet Pathway to Prevention participants
Diabetologia. 2016 Jun;59(6):1186-95. doi: 10.1007/s00125-016-3924-5. Epub 2016 Mar 19
扩展阅读